Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. Zymeworks is committed to developing best-in-class protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases.
The Company's approach combines proprietary molecular modeling and simulation software with high-performance computing to create an environment for in silico experimentation and predictive protein optimization. Using this approach Zymeworks has developed multiple platform technologies to advance the field of biologics drug discovery and optimization.
Market capitalization (25-Jan-2022)
Closing stock price (25-Jan-2022)
Zymeworks has 1.18k Twitter Followers. The number of followers has increased 1.8% month over month and increased 2.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Zymeworks founded?
Zymeworks was founded in 2003.
Who are Zymeworks key executives?
Zymeworks's key executives are Ali Tehrani, Neil Klompas and Tony Polverino.
How many employees does Zymeworks have?
Zymeworks has 455 employees.
Who are Zymeworks competitors?
Competitors of Zymeworks include NovoCure, Neovii and SQZ Biotech.
Where is Zymeworks headquarters?
Zymeworks headquarters is located at 1385 W 8th Ave #540, Vancouver.
Where are Zymeworks offices?
Zymeworks has offices in Vancouver and Seattle.
How many offices does Zymeworks have?
Zymeworks has 2 offices.
Receive alerts for 300+ data fields across thousands of companies